Mega Lifesciences PCL
SET:MEGA
Mega Lifesciences PCL?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24.5
41
|
Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?
What risks and challenges
does Mega Lifesciences PCL face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Mega Lifesciences PCL.
Provide an overview of the primary business activities
of Mega Lifesciences PCL.
What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?
What risks and challenges
does Mega Lifesciences PCL face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Mega Lifesciences PCL.
Provide P/S
for Mega Lifesciences PCL.
Provide P/E
for Mega Lifesciences PCL.
Provide P/OCF
for Mega Lifesciences PCL.
Provide P/FCFE
for Mega Lifesciences PCL.
Provide P/B
for Mega Lifesciences PCL.
Provide EV/S
for Mega Lifesciences PCL.
Provide EV/GP
for Mega Lifesciences PCL.
Provide EV/EBITDA
for Mega Lifesciences PCL.
Provide EV/EBIT
for Mega Lifesciences PCL.
Provide EV/OCF
for Mega Lifesciences PCL.
Provide EV/FCFF
for Mega Lifesciences PCL.
Provide EV/IC
for Mega Lifesciences PCL.
Show me price targets
for Mega Lifesciences PCL made by professional analysts.
What are the Revenue projections
for Mega Lifesciences PCL?
How accurate were the past Revenue estimates
for Mega Lifesciences PCL?
What are the Net Income projections
for Mega Lifesciences PCL?
How accurate were the past Net Income estimates
for Mega Lifesciences PCL?
What are the EPS projections
for Mega Lifesciences PCL?
How accurate were the past EPS estimates
for Mega Lifesciences PCL?
What are the EBIT projections
for Mega Lifesciences PCL?
How accurate were the past EBIT estimates
for Mega Lifesciences PCL?
Compare the revenue forecasts
for Mega Lifesciences PCL with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Mega Lifesciences PCL and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Mega Lifesciences PCL against its competitors.
Analyze the profit margins
(gross, operating, and net) of Mega Lifesciences PCL compared to its peers.
Compare the P/E ratios
of Mega Lifesciences PCL against its peers.
Discuss the investment returns and shareholder value creation
comparing Mega Lifesciences PCL with its peers.
Analyze the financial leverage
of Mega Lifesciences PCL compared to its main competitors.
Show all profitability ratios
for Mega Lifesciences PCL.
Provide ROE
for Mega Lifesciences PCL.
Provide ROA
for Mega Lifesciences PCL.
Provide ROIC
for Mega Lifesciences PCL.
Provide ROCE
for Mega Lifesciences PCL.
Provide Gross Margin
for Mega Lifesciences PCL.
Provide Operating Margin
for Mega Lifesciences PCL.
Provide Net Margin
for Mega Lifesciences PCL.
Provide FCF Margin
for Mega Lifesciences PCL.
Show all solvency ratios
for Mega Lifesciences PCL.
Provide D/E Ratio
for Mega Lifesciences PCL.
Provide D/A Ratio
for Mega Lifesciences PCL.
Provide Interest Coverage Ratio
for Mega Lifesciences PCL.
Provide Altman Z-Score Ratio
for Mega Lifesciences PCL.
Provide Quick Ratio
for Mega Lifesciences PCL.
Provide Current Ratio
for Mega Lifesciences PCL.
Provide Cash Ratio
for Mega Lifesciences PCL.
What is the historical Revenue growth
over the last 5 years for Mega Lifesciences PCL?
What is the historical Net Income growth
over the last 5 years for Mega Lifesciences PCL?
What is the current Free Cash Flow
of Mega Lifesciences PCL?
Discuss the annual earnings per share (EPS)
trend over the past five years for Mega Lifesciences PCL.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
TH |
M
|
Mega Lifesciences PCL
SET:MEGA
|
25.5B THB | 6.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
770.2B USD | 37.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
404.9B USD | 13.6 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.2B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.7B CHF | 10 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.5B GBP | 131.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
213.1B USD | 9 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
140.9B USD | 7.6 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
TH |
M
|
Mega Lifesciences PCL
SET:MEGA
|
Average EV/EBITDA:
397.8
6.1
|
-2%
|
N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
37.2
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.6
|
7%
|
1.9 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.3
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10
|
5%
|
2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131.1
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.6
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.